TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IBRX

Immunitybio Inc

Healthcare · Biotechnology

8.60$ +0.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Immunitybio Inc (IBRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 629 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IBRX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
332 317 304 302 278 250 230 211 202 182 208 176 160 143 127 196 117 221 209 246 214 469 390 318 353 362 343 291 432 504 401 444 365 383 304 402 519 502 647 629
214 205 196 182 157 132 127 110 101 89 113 87 72 56 44 115 79 112 100 114 94 334 212 115 143 141 113 67 215 294 196 243 163 185 109 208 329 315 453 439
31 8.1 14 39 21 24 11 16 15 17 22 17 18 16 17 103 57 35 45 84 65 181 36 62 104 105 88 44 178 265 133 130 112 143 61 138 60 88 205 76
209 199 191 176 152 128 122 105 83 74 99 84 66 52 40 111 62 96 83 104 80 317 192 83 111 107 91 46 190 266 170 218 130 150 62 154 258 243 381 357
1.3 2.7 1.3 2.6 1.3 1.3 2.2 3.0 14 12 12 0.8 0.4 0.3 0.3 0.1 0.6 2.0 2.1 2.0 1.3 1.3 3.9 1.5 6.5 1.9 1.5 3.3 2.3 3.2 2.1 2.1 4.9 2.7 17 22 34 43 43 53
– – – – – – – – – – – – – -0.3 – – -0.6 – 10.0 6.8 7.9 – 12 2.2 20 26 16 13 16 – – 1.8 2.0 8.3 8.4 6.6 6.7 0.9 0.5 1.9
– – – – – – – – – – – – – 28 70 69 70 29 99 117 70 83 105 168 130 144 154 151 – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 0.9 0.9 0.9 0.9 0.9 0.9 0.9 12
5.9 5.1 4.5 4.0 3.4 2.8 2.3 1.7 1.1 0.6 0.6 – – 12 – – 1.4 1.5 1.4 1.6 1.4 1.4 22 22 20 20 20 19 18 17 17 16 16 15 15 14 14 13 12 12
22 24 25 49 40 32 29 30 40 36 40 24 24 22 24 27 314 340 395 405 404 713 727 740 782 812 875 936 843 1,090 1,092 1,142 1,109 871 894 972 1,042 1,001 1,516 1,674
10 13 14 37 29 21 19 20 30 27 28 12 13 12 14 17 54 68 80 74 65 369 381 376 71 501 565 613 90 58 54 62 61 55 49 51 57 62 68 77
0.2 0.2 0.2 – – 0.2 – – – – – – – 4.0 3.5 3.1 1.4 5.0 5.7 2.4 7.2 302 303 301 1.4 435 474 524 4.4 5.2 6.1 6.2 7.0 7.5 7.5 7.4 7.3 9.3 8.6 7.5
2.2 4.0 4.3 4.3 9.5 5.9 3.6 5.5 3.5 2.8 2.8 1.9 2.1 1.7 3.1 4.0 10 12 20 19 15 11 9.8 18 20 21 34 25 20 9.2 14 20 9.9 6.7 14 7.4 5.8 7.0 11 12
– – – – – – – – – – – – – – – – – 254 297 300 303 306 309 313 661 241 246 250 674 682 687 693 699 462 486 492 501 477 678 774
311 293 278 253 238 219 200 182 162 146 168 151 136 121 103 170 -200 -120 -186 -158 -188 -242 -336 -420 -427 -447 -529 -642 -412 -587 -692 -698 -745 -489 -591 -571 -524 -500 -870 -1,047
-359 -387 -413 -447 -471 -499 -526 -554 -577 -595 -614 -631 -647 -662 -681 -701 -823 -1,615 -1,695 -1,783 -1,871 -1,962 -2,065 -2,159 -2,270 -2,378 -2,495 -2,633 -2,728 -2,962 -3,096 -3,230 -3,316 -3,375 -3,505 -3,597 -3,665 -3,727 -4,359 -4,590
329 329 329 326 318 316 316 316 317 325 325 394 393 332 383 383 383 383 383 385 392 397 398 398 400 404 428 437 498 591 673 687 698 735 853 888 947 990 1,027 1,050

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?